Alejandro Balazs

Alejandro Balazs

Harvard University

H-index: 39

North America-United States

About Alejandro Balazs

Alejandro Balazs, With an exceptional h-index of 39 and a recent h-index of 35 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Engineering Immunity, Virology, HIV, SARS-CoV-2, Evolution and Escape.

His recent articles reflect a diverse array of research interests and contributions to the field:

Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation

Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells

Resolution of SARS-CoV-2 infection in human lung tissues is driven by extravascular CD163+ monocytes (preprint)

Broad immunogenicity to prior SARS-CoV-2 strains and JN. 1 variant elicited by XBB. 1.5 vaccination in nursing home residents

mRNA-based monkeypox virus vaccine prevents disease in non-human primates

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Response in Adults with Predominantly Antibody Deficiency

Immunophenotypic Risk Factors for Low SARS-CoV-2 Immunization Response in Adults with Predominantly Antibody Deficiency over Five Total Vaccine Doses

SARS-CoV-2 Vaccine Response Following Five Total Vaccine Doses in Adult Patients with Predominantly Antibody Deficiency (PAD)

Alejandro Balazs Information

University

Position

Assistant Professor at the Ragon Institute of MGH, MIT and Harvard

Citations(all)

10916

Citations(since 2020)

8364

Cited By

4010

hIndex(all)

39

hIndex(since 2020)

35

i10Index(all)

67

i10Index(since 2020)

66

Email

University Profile Page

Google Scholar

Alejandro Balazs Skills & Research Interests

Engineering Immunity

Virology

HIV

SARS-CoV-2

Evolution and Escape

Top articles of Alejandro Balazs

Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation

ACS Infectious Diseases

2024/1/28

Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells

bioRxiv

2024

Alejandro Balazs
Alejandro Balazs

H-Index: 25

Resolution of SARS-CoV-2 infection in human lung tissues is driven by extravascular CD163+ monocytes (preprint)

2024

Broad immunogenicity to prior SARS-CoV-2 strains and JN. 1 variant elicited by XBB. 1.5 vaccination in nursing home residents

medRxiv

2024/3/24

mRNA-based monkeypox virus vaccine prevents disease in non-human primates

Cell

2024/3/14

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Response in Adults with Predominantly Antibody Deficiency

Clinical Infectious Diseases

2022/2/1

Immunophenotypic Risk Factors for Low SARS-CoV-2 Immunization Response in Adults with Predominantly Antibody Deficiency over Five Total Vaccine Doses

Journal of Allergy and Clinical Immunology

2024/2/1

SARS-CoV-2 Vaccine Response Following Five Total Vaccine Doses in Adult Patients with Predominantly Antibody Deficiency (PAD)

Journal of Allergy and Clinical Immunology

2024/2/1

Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds

Nature Communications

2024/1/30

Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residents

2023/12/1

Rheumatoid arthritis and older age are associated with lower humoral and cellular immune response to primary series COVID-19 mRNA vaccine

Vaccine

2023/9/22

Delivery platforms for broadly neutralizing antibodies

2023/7/1

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses

Virology

2023/6/1

Brief report: declining rates of SARS-CoV-2 vaccine uptake among patients with thoracic malignancies

Clinical Lung Cancer

2023/6/1

Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers

Vaccine

2023/5/22

Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination

medRxiv

2023/4/25

Diagnostic TR-FRET assays for detection of antibodies in patient samples

Cell Reports Methods

2023/3/27

Association of cytomegalovirus serostatus With severe acute respiratory syndrome coronavirus 2 vaccine responsiveness in nursing home residents and healthcare workers

Open forum infectious diseases

2023/2/1

SARS-CoV-2 antibody responses to the ancestral SARS-CoV-2 strain and omicron BA. 1 and BA. 4/BA. 5 variants in nursing home residents after receipt of bivalent COVID-19 vaccine …

MMWR. Morbidity and Mortality Weekly Report

2023

COVID-19 booster dose induces robust antibody response in pregnant, lactating, and nonpregnant women

American Journal of Obstetrics and Gynecology

2023/1/1

See List of Professors in Alejandro Balazs University(Harvard University)

Co-Authors

academic-engine